Mesenchymal Stem Cell (MSC) Markers

Loading

  • Mesenchymal stem cells (MSCs) are multipotent stromal cells capable of differentiating into various cell types, including osteoblasts, adipocytes, and chondrocytes. 
  • They are primarily isolated from bone marrow but also exist in other tissues such as adipose tissue, umbilical cord, and dental pulp. 
  • Mesenchymal stem cells are defined not only by their plastic adherence and differentiation potential but also by a unique surface marker profile. 
  • MSCs are characterized by specific surface markers that distinguish them from hematopoietic and other cell types, as well as by their functional capabilities.
  • The International Society for Cellular Therapy (ISCT) has proposed minimal criteria for defining human MSCs:
    • They must adhere to plastic under standard culture conditions.
    • They must express a specific set of surface markers.
    • They must differentiate into osteoblasts, adipocytes, and chondroblasts in vitro.

MSCs express a distinct profile of positive and negative surface markers:

  • Positive Markers (typically expressed):
    • CD105 (Endoglin): A TGF-β receptor accessory protein involved in angiogenesis and cell proliferation. Highly expressed on MSCs.
    • CD73 (Ecto-5′-nucleotidase): An enzyme involved in purine metabolism, associated with immunomodulatory functions.
    • CD90 (Thy-1): A glycoprotein linked with cell adhesion and signal transduction.
    • CD44: A receptor for hyaluronic acid, important for cell–matrix interactions.
    • CD29 (Integrin β1): Plays a role in cell adhesion and interaction with the extracellular matrix.
    • CD146 (MCAM): A cell adhesion molecule; sometimes used to identify subpopulations of MSCs with enhanced differentiation potential.
    • Stro-1: An early marker of MSCs, especially in bone marrow-derived populations.
  • Negative Markers (not expressed):
    • CD34: A marker for hematopoietic progenitor and endothelial cells.
    • CD45: A pan-leukocyte marker.
    • CD14/CD11b: Markers for monocytes and macrophages.
    • CD79a/CD19: B cell markers.
    • HLA-DR: An MHC class II surface receptor; MSCs typically do not express it under baseline conditions but may upregulate it in response to inflammatory cytokines.
  • Functional Markers and Emerging Candidates: In addition to surface markers, MSCs may also express markers related to their immunomodulatory and differentiation potential, such as:
    • Nestin: An intermediate filament protein expressed in MSCs with neural differentiation potential.
    • SSEA-4 (Stage-Specific Embryonic Antigen-4): Sometimes used to identify early progenitor MSCs.
    • ALCAM (CD166): Involved in adhesion and migration, also expressed in MSCs.
Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *